HUM - Humana - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4448591028
Medical Insurance, Specialty Insurance, Pharmacy Benefits, Home Care Services
Humana Inc. is a leading health insurance company in the United States, offering a wide range of medical and specialty insurance products to individuals, employers, and government agencies. Through its two main segments, Insurance and CenterWell, the company provides a diverse portfolio of health insurance plans, including medical, supplemental, and specialty benefits.
The company's insurance products cater to various demographics, including individuals, seniors, and military personnel. For instance, Humana has a contract with the Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program. Additionally, it partners with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Humana's commercial insurance offerings include fully-insured medical and specialty health insurance benefits, such as dental, vision, and life insurance, as well as administrative services only products. The company also provides military services, including the TRICARE T2017 East Region contract. Furthermore, it operates a pharmacy benefit manager business, which helps manage prescription drug benefits for its members.
In addition to its insurance products, Humana operates a network of pharmacies and senior-focused primary care centers, offering convenient access to healthcare services for its members. The company also provides home solutions services, including home health, hospice, and other services, to both its health plan members and third-party clients.
Humana's products are sold through a variety of channels, including employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. This diversified distribution network enables the company to reach a broad customer base across the United States.
Founded in 1961, Humana Inc. is headquartered in Louisville, Kentucky, and has a rich history of providing innovative health insurance solutions to its members. Today, the company is a leading player in the US health insurance market, with a strong commitment to improving the health and well-being of its members.
For more information about Humana Inc. and its products, please visit its website at https://www.humana.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
HUM Stock Overview
Market Cap in USD | 37,593m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC SubIndustry | Managed Health Care |
TER | 0.00% |
IPO / Inception | 1993-01-22 |
HUM Stock Ratings
Growth 5y | -2.27 |
Fundamental | 3.15 |
Dividend | 27.4 |
Rel. Performance vs Sector | -3.17 |
Analysts | 3.80/5 |
Fair Price Momentum | 243.94 USD |
Fair Price DCF | 616.83 USD |
HUM Dividends
Dividend Yield 12m | 1.47% |
Yield on Cost 5y | 1.44% |
Dividends CAGR 5y | 9.98% |
Payout Consistency | 49.9% |
HUM Growth Ratios
Growth 12m | -51.35% |
Growth Correlation 12m | -67% |
Growth Correlation 3m | -88% |
CAGR 5y | -0.49% |
CAGR/Mean DD 5y | -0.04 |
Sharpe Ratio 12m | -1.52 |
Alpha vs SP500 12m | -84.28 |
Beta vs SP500 5y weekly | 0.93 |
ValueRay RSI | 3.14 |
Volatility GJR Garch 1y | 74.95% |
Price / SMA 50 | -28.9% |
Price / SMA 200 | -32.8% |
Current Volume | 3608.7k |
Average Volume 20d | 3120.2k |
External Links for HUM Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 05, 2024, the stock is trading at USD 240.03 with a total of 3,608,699 shares traded.
Over the past week, the price has changed by -24.68%, over one month by -35.19%, over three months by -34.74% and over the past year by -51.67%.
According to ValueRays Forecast Model, HUM Humana will be worth about 266 in October 2025. The stock is currently trading at 240.03. This means that the stock has a potential upside of +10.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 392 | 63.3 |
Analysts Target Price | 587.5 | 145 |
ValueRay Target Price | 266 | 10.8 |